Alexithymia among long-term drug users: a pilot study in Oporto

dc.contributor.authorSouto, Maria Teresa Soares
dc.contributor.authorAlves, Hélder
dc.contributor.authorDias, Ana Rita Conde
dc.contributor.authorPinto, Luísa
dc.contributor.authorRibeiro, Óscar
dc.date.accessioned2022-01-21T09:57:43Z
dc.date.available2022-01-21T09:57:43Z
dc.date.issued2019-09-18
dc.description.abstractIncreasing scientific evidence supports an association between alexithymia and psychoactive substance use. This study explores alexithymia ́s expression in sample of long-term drug users, undergoing outpatient treatment in public health units in Oporto, Portugal, as well as its ́ association with social demographic risk factors. Data was collected from a sample of 90 adults, participants, mainly men (n=90; 87%), considered to be old consumers (81% with a age>40 years), with a mean age of 46.1 years (SD=8.3; range=21–64).Two instruments were used: a sociodemographic questionnaire and the 20-item Toronto Alexithymia Scale (TAS-20). More than 51.1% of the individuals were alexithymic, indicating a high prevalence of deficits in emotional awareness. The treatment period varied from 0 to 15 years, included a medication in 55% of cases, mostly methadone (83%). This profile illustrates the gradual aging of the long-term users of illicit drugs and alcohol with a clear diagnosis of an emotional disorder. Therefore, clinicians who develop treatment strategies may want to take into account the likelihood that many of their patients may be alexithymic; in being so, they should integrate specific psychotherapeutic techniques that promote both the identification and the differentiation in emotionally dysfunctional patients.pt
dc.formatapplication/pdf
dc.identifier.citationSouto, T., Alves, H., Conde, A.R., Pinto, L., & Ribeiro, O. (2019). Alexithymia among long-term drug users: a pilot study in Oporto. Journal of psychology and clinical psychiatry., 10 (5), 181-185.pt
dc.identifier.otherDOI: 10.15406/jpcpy.2019.10.00650
dc.identifier.urihttp://hdl.handle.net/10437/12444
dc.language.isoengpt
dc.publisherMedCravept
dc.rightsopenAccess
dc.subjectALEXITHYMIAen
dc.subjectDRUGS CONSUMPTIONen
dc.subjectMENTAL HEALTHen
dc.subjectTAS-20en
dc.subjectFATORES DE RISCOpt
dc.subjectPSICOLOGIApt
dc.subjectPSYCHOLOGYen
dc.subjectALEXITIMIApt
dc.subjectCONSUMO DE DROGASpt
dc.subjectSAÚDE MENTALpt
dc.subjectRISK FACTORSen
dc.titleAlexithymia among long-term drug users: a pilot study in Oportopt
dc.typearticlept

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
JPCPY-10-00650.pdf
Tamanho:
539.17 KB
Formato:
Adobe Portable Document Format
Descrição:
Increasing scientific evidence supports an association between alexithymia and psychoactive substance use. This study explores alexithymia ́s expression in sample of long-term drug users, undergoing outpatient treatment in public health units in Oporto, Portugal, as well as its ́ association with social demographic risk factors. Data was collected from a sample of 90 adults, participants, mainly men (n=90; 87%), considered to be old consumers (81% with a age>40 years), with a mean age of 46.1 years (SD=8.3; range=21–64).Two instruments were used: a sociodemographic questionnaire and the 20-item Toronto Alexithymia Scale (TAS-20). More than 51.1% of the individuals were alexithymic, indicating a high prevalence of deficits in emotional awareness. The treatment period varied from 0 to 15 years, included a medication in 55% of cases, mostly methadone (83%). This profile illustrates the gradual aging of the long-term users of illicit drugs and alcohol with a clear diagnosis of an emotional disorder. Therefore, clinicians who develop treatment strategies may want to take into account the likelihood that many of their patients may be alexithymic; in being so, they should integrate specific psychotherapeutic techniques that promote both the identification and the differentiation in emotionally dysfunctional patients.
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: